EQS-Adhoc: Bayer Aktiengesellschaft: Bayer secures 3.0 billion euros to improve capital structure
|
EQS-Ad-hoc: Bayer Aktiengesellschaft / Key word(s): Other Leverkusen, July 10, 2026 – Bayer has secured 3.0 billion euros in equity capital to improve its capital structure. The company signed a respective agreement with the global asset management firm Apollo on Friday. Under the agreement, Apollo-managed funds and affiliates will obtain a minority, non-controlling stake in a newly established entity holding Bayer’s long-acting reversible contraceptives (LARC) business. Bayer will retain a majority stake in the entity and will continue to exercise complete operational control over the business. There will be no changes to the LARC strategy or business activities as a result of the investment. The LARC activities will continue to form part of the Bayer Pharmaceuticals Division’s core business, and the entity will remain fully consolidated in the Consolidated Financial Statements of the Bayer Group.
The transaction enhances Bayer’s financial flexibility as the company manages increased liquidity requirements this year related to bond maturities and litigation procedures, while continuing to execute its long-term priorities. The transaction is expected to close in the third quarter of 2026, subject to approval by antitrust authorities and customary closing conditions. Forward-Looking Statements This notification may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Bayer AG is a holding company with operating subsidiaries worldwide. References to “Bayer” or “the company” herein may refer to one or more subsidiaries as context requires. Contact: Mrs. Denise Jahn. Bayer AG, Investor Relations, Phone: +49-214-30-72704, e-mail: denise.jahn@bayer.com End of Inside Information Explanation, why the information directly concerns that issuer: Contact for investor inquiries: Bayer Investor Relations Team, phone +49 214 30-72704 Email: ir@bayer.com www.bayer.com/en/investors/ir-team
10-Jul-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Bayer Aktiengesellschaft |
| Kaiser-Wilhelm-Allee 1 | |
| 51373 Leverkusen | |
| Germany | |
| Phone: | +49 (0)214 30-72704 |
| E-mail: | ir@bayer.com |
| Internet: | www.bayer.com |
| ISIN: | DE000BAY0017 |
| WKN: | BAY001 |
| Indices: | DAX, EURO STOXX 50, Stoxx 50 |
| Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2363770 |
| End of Announcement | EQS News Service |
|
|
2363770 10-Jul-2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 41.400,00 | 44.081,00 | 50.739,00 | 47.637,00 | 46.606,00 | 45.575,00 | 46.260,00 | |
| EBITDA1,2 | -2.910,00 | 6.409,00 | 13.515,00 | 10.632,00 | 8.712,00 | 1.708,00 | 9.800,00 | |
| EBITDA-Margin3 | -7,03 | 14,54 | 26,64 | 22,32 | 18,69 | 3,75 | 21,19 | |
| EBIT1,4 | -16.169,00 | 3.353,00 | 7.012,00 | 6.460,00 | -71,00 | -1.077,00 | 5.400,00 | |
| EBIT-Margin5 | -39,06 | 7,61 | 13,82 | 13,56 | -0,15 | -2,36 | 11,67 | |
| Net Profit (Loss)1 | -10.487,00 | 1.022,00 | 4.166,00 | -2.942,00 | -2.546,00 | -3.950,00 | 2.750,00 | |
| Net-Margin6 | -25,33 | 2,32 | 8,21 | -6,18 | -5,46 | -8,67 | 5,95 | |
| Cashflow1,7 | 4.903,00 | 5.089,00 | 7.093,00 | 5.117,00 | 7.368,00 | 5.930,00 | 0,00 | |
| Earnings per share8 | -10,68 | 1,02 | 4,22 | -2,99 | -2,60 | -3,68 | 2,80 | |
| Dividend per share8 | 2,00 | 2,00 | 2,40 | 0,11 | 0,11 | 0,11 | 0,11 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Deloitte
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Bayer | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| BAY001 | DE000BAY0017 | AG | 46.291,82 Mio € | 01.05.1948 | Halten | 9F382X7M+F6 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 15,71 | 22,97 | 0,68 | 190,77 | 1,79 | 7,81 | 1,02 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,11 | 0,11 | 0,11 | 0,23% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 30.04.2027 | 12.05.2026 | 04.08.2026 | 03.11.2026 | 24.02.2027 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +11,36% | +21,79% | +27,32% | +67,57% | +0,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
